These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21240808)

  • 1. Pragmatic and proportional analysis of conflict of interest.
    Bean S
    Am J Bioeth; 2011 Jan; 11(1):39-40. PubMed ID: 21240808
    [No Abstract]   [Full Text] [Related]  

  • 2. IOM warns about physician-pharma conflicts of interest.
    Landers SJ; O'Reilly KB
    Del Med J; 2009 Jul; 81(7):261-3. PubMed ID: 19902777
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond a pejorative understanding of conflict of interest.
    Williams-Jones B
    Am J Bioeth; 2011 Jan; 11(1):1-2. PubMed ID: 21240793
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlling conflict of interest--proposals from the Institute of Medicine.
    Steinbrook R
    N Engl J Med; 2009 May; 360(21):2160-3. PubMed ID: 19403898
    [No Abstract]   [Full Text] [Related]  

  • 5. Conflict of interest in the physician interface with the biomedical industry.
    Minnigan H; Chisholm CD
    Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doctors and drug companies.
    Blumenthal D
    N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
    [No Abstract]   [Full Text] [Related]  

  • 7. Under the influence? IOM conflict-of-interest report raises concerns.
    Rhea S
    Mod Healthc; 2009 May; 39(18):8-9. PubMed ID: 19472501
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical students protest perks from drug companies.
    Opar A
    Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
    [No Abstract]   [Full Text] [Related]  

  • 9. Responses to peer commentaries on "Clarifying conflict of interest".
    Brody H
    Am J Bioeth; 2011 Jan; 11(1):W4-5. PubMed ID: 21240796
    [No Abstract]   [Full Text] [Related]  

  • 10. Can the Institute of Medicine review the FDA?
    Carroll BJ
    Nat Med; 2005 Apr; 11(4):369. PubMed ID: 15812509
    [No Abstract]   [Full Text] [Related]  

  • 11. Distributions of industry payments to Massachusetts physicians.
    Kesselheim AS; Robertson CT; Siri K; Batra P; Franklin JM
    N Engl J Med; 2013 May; 368(22):2049-52. PubMed ID: 23635021
    [No Abstract]   [Full Text] [Related]  

  • 12. Harmonizing reporting of financial conflicts.
    Kuehn BM
    JAMA; 2013 Jan; 309(1):19. PubMed ID: 23280201
    [No Abstract]   [Full Text] [Related]  

  • 13. Conflicts of interest. IOM panel backs public disclosure of drug company payments.
    Kaiser J
    Science; 2009 May; 324(5927):579. PubMed ID: 19407172
    [No Abstract]   [Full Text] [Related]  

  • 14. Trustworthiness in conflict of interest.
    Hurst SA; Mauron A
    Am J Bioeth; 2011 Jan; 11(1):40-1. PubMed ID: 21240809
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to "Can the Institute of Medicine review the FDA?".
    Fineberg HV
    Nat Med; 2005 Jun; 11(6):589. PubMed ID: 15937463
    [No Abstract]   [Full Text] [Related]  

  • 16. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
    Quan SF
    J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
    [No Abstract]   [Full Text] [Related]  

  • 17. Toward a harmonized and centralized conflict of interest disclosure: progress from an IOM initiative.
    Lichter AS; McKinney R
    JAMA; 2012 Nov; 308(20):2093-4. PubMed ID: 23188024
    [No Abstract]   [Full Text] [Related]  

  • 18. Doctors and drug companies.
    Lambert LA
    N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
    [No Abstract]   [Full Text] [Related]  

  • 19. Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.
    Rosenthal MB; Mello MM
    N Engl J Med; 2013 May; 368(22):2052-4. PubMed ID: 23718162
    [No Abstract]   [Full Text] [Related]  

  • 20. New rules on conflict of interest: what has to be done in Europe?
    Jirillo A; Vascon F
    Tumori; 2010; 96(1):180-1. PubMed ID: 20437882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.